Second Chinese drugmaker seeks approval for Ozempic generic
By Andrew Silver SHANGHAI (Reuters) – A second Chinese drugmaker has applied for approval to sell a generic version of Novo Nordisk’s blockbuster diabetes drug Ozempic in China. Livzon Pharmaceutical Group said this week its subsidiary was seeking approval to sell the drug to control blood sugar in patients with type 2 diabetes and reduce …
Second Chinese drugmaker seeks approval for Ozempic generic Read More »









